Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003224-40

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to demonstrate the safety and tolerability of fulranumab subcutaneous (SC) injections compared with SC placebo, in subjects with standard of care and who have signs and symptoms of osteoarthritis of the hip or knee.


Critère d'inclusion

  • Osteoarthritis of the hip or knee